Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A regenerative endodontic treatment combination consisting of an induced blood clot scaffold supplemented with autologous platelet-rich fibrin (PRF). This combination is used to treat immature permanent teeth with necrotic pulp. The procedure involves inducing apical bleeding to fill the root canal with blood, followed by the placement of a PRF membrane, which is a second-generation platelet concentrate rich in growth factors and cytokines. This bioactive scaffold promotes the migration and differentiation of stem cells from the periapical tissues, aiming to achieve root maturation and pulp-dentin complex regeneration. The treatment is typically completed with a coronal seal using a bioceramic material such as Biodentine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on blood clot scaffold + platelet-rich fibrin.